{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:54:03Z","timestamp":1781679243446,"version":"3.54.5"},"reference-count":55,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2007,4,1]],"date-time":"2007-04-01T00:00:00Z","timestamp":1175385600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Cancer Letters"],"published-print":{"date-parts":[[2007,4]]},"DOI":"10.1016\/j.canlet.2006.12.029","type":"journal-article","created":{"date-parts":[[2007,2,16]],"date-time":"2007-02-16T12:21:47Z","timestamp":1171628507000},"page":"5-13","source":"Crossref","is-referenced-by-count":33,"title":["Molecular markers for prostate cancer"],"prefix":"10.1016","volume":"249","author":[{"given":"Mark A.","family":"Reynolds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumar","family":"Kastury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack","family":"Groskopf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack A.","family":"Schalken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Rittenhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canlet.2006.12.029_bib1","first-page":"136","article-title":"Screening for prostate cancer in 2006: PSA in the 21st century","volume":"67","author":"Maroni","year":"2006","journal-title":"N. C. Med. J."},{"key":"10.1016\/j.canlet.2006.12.029_bib2","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.urology.2005.12.026","article-title":"Prostate-specific antigen: Update 2006","volume":"67","author":"Freedland","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.029_bib3","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.urology.2006.02.030","article-title":"Prostate-specific antigen-based serial screening may decrease prostate cancer-specific mortality","volume":"68","author":"Efstathiou","year":"2006","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.029_bib4","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1093\/jnci\/djj131","article-title":"Assessing prostate cancer risk: Results from the prostate cancer prevention trial","volume":"98","author":"Thompson","year":"2006","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2006.12.029_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/clinchem\/47.4.631","article-title":"Preoperative serum prostate-specific antigen (PSA) below 10 microg\/l predicts neither the presence of prostate cancer nor the rate of postoperative PSA failure","volume":"47","author":"Stamey","year":"2001","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.029_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.clinbiochem.2004.05.016","article-title":"Are multiple markers the future of prostate cancer diagnostics?","volume":"37","author":"Mikolajczyk","year":"2004","journal-title":"Clin. Biochem."},{"key":"10.1016\/j.canlet.2006.12.029_bib7","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1074\/mcp.R200007-MCP200","article-title":"The human plasma proteome: history, character, and diagnostic prospects","volume":"1","author":"Anderson","year":"2002","journal-title":"Mol. Cell. Proteom."},{"key":"10.1016\/j.canlet.2006.12.029_bib8","first-page":"146","article-title":"A case of cancer in which cells similar to those in the tumours where seen in the blood after death","volume":"14","author":"Ashworth","year":"1869","journal-title":"Aust. Med. J."},{"key":"10.1016\/j.canlet.2006.12.029_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1093\/clinchem\/41.10.1410","article-title":"Can molecular markers now be used for early diagnosis of malignancy?","volume":"41","author":"Duffy","year":"1995","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.029_bib10","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.euus.2005.09.005","article-title":"Molecular diagnostics in prostate cancer","volume":"3","author":"Hessels","year":"2005","journal-title":"EAU Update Series Series"},{"key":"10.1016\/j.canlet.2006.12.029_bib11","doi-asserted-by":"crossref","first-page":"5427","DOI":"10.1038\/sj.onc.1205600","article-title":"CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future","volume":"21","author":"Esteller","year":"2002","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2006.12.029_bib12","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1101\/sqb.2005.70.010","article-title":"Aberrant gene silencing in tumor progression: Implications for control of cancer","volume":"70","author":"Baylin","year":"2005","journal-title":"Cold Spring Harb. Symp. Quant. Biol."},{"key":"10.1016\/j.canlet.2006.12.029_bib13","first-page":"514","article-title":"Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features","volume":"8","author":"Maruyama","year":"2002","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib14","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/jcp.56.1.52","article-title":"Endothelin B receptor gene hypermethylation in prostate adenocarcinoma","volume":"56","author":"Jeronimo","year":"2003","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.canlet.2006.12.029_bib15","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/pros.20013","article-title":"Heterogeneous gene methylation patterns among pre-invasive and cancerous lesions of the prostate: a histopathologic study of whole mount prostate specimens","volume":"60","author":"Woodson","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2006.12.029_bib16","doi-asserted-by":"crossref","first-page":"5518","DOI":"10.1158\/1078-0432.CCR-04-0108","article-title":"Optimal use of a panel of methylation markers with GSTP1 hypermethylation in the diagnosis of prostate adenocarcinoma","volume":"10","author":"Tokumaru","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib17","first-page":"631","article-title":"Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease","volume":"12","author":"Singal","year":"2004","journal-title":"Onco. Rep."},{"key":"10.1016\/j.canlet.2006.12.029_bib18","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1158\/1078-0432.CCR-04-0894","article-title":"A quantitative promoter methylation profile of prostate cancer","volume":"10","author":"Jeronimo","year":"2004","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib19","doi-asserted-by":"crossref","first-page":"6582","DOI":"10.1158\/1078-0432.CCR-05-0658","article-title":"Multigene methylation analysis for detection and staging of prostate cancer","volume":"11","author":"Enokida","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib20","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1158\/1078-0432.CCR-04-1832","article-title":"Diagnostic and prognostic information in prostate cancer with the help of a small set of hypermethylated gene loci","volume":"11","author":"Bastian","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib21","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1158\/1078-0432.CCR-04-2446","article-title":"Preoperative serum DNA GSTP1 CpG island hypermethylation and the risk of early prostate-specific antigen recurrence following radical prostatectomy","volume":"11","author":"Bastian","year":"2005","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1586\/14737159.3.4.459","article-title":"Prostate cancer biomarkers: a current perspective","volume":"3","author":"Kumar-Sinha","year":"2003","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.canlet.2006.12.029_bib23","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11934-004-0011-0","article-title":"Molecular profiling of prostate cancer","volume":"5","author":"Huppi","year":"2004","journal-title":"Curr. Urol. Rep."},{"key":"10.1016\/j.canlet.2006.12.029_bib24","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/01.ju.0000142067.17181.68","article-title":"Predicting prostate cancer behavior using transcript profiles","volume":"172","author":"Nelson","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.029_bib25","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/BF02893851","article-title":"Genomics of prostate cancer: Is there anything to \u201ctranslate\u201d?","volume":"11","author":"Kopper","year":"2005","journal-title":"Pathol. Oncol. Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib26","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1586\/14737159.4.4.513","article-title":"Applicability of biomarkers in the early diagnosis of prostate cancer","volume":"4","author":"Hessels","year":"2004","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.canlet.2006.12.029_bib27","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.1097\/01.ju.0000141781.70474.48","article-title":"Expression of genes and proteins specific for prostate cancer","volume":"172","author":"Gelmann","year":"2004","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.029_bib28","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1586\/14737159.6.4.535","article-title":"Microarray RNA transcriptional profiling: Part I. platforms, experimental design and standardization","volume":"6","author":"Ahmed","year":"2006","journal-title":"Expert Rev. Mol. Diagn."},{"key":"10.1016\/j.canlet.2006.12.029_bib29","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/sj.bjc.6602261","article-title":"Expression analysis onto microarrays of randomly selected cDNA clones highlights HOXB13 as a marker of human prostate cancer","volume":"92","author":"Edwards","year":"2005","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.canlet.2006.12.029_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/pros.20012","article-title":"and P775P: A genomic cluster of prostate-specific genes","volume":"60","author":"Stolk","year":"2004","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2006.12.029_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/01.pap.0000146924.14246.be","article-title":"Diagnostic utility of alpha-methylacyl CoA racemase (P504S) on prostate needle biopsy","volume":"11","author":"Jiang","year":"2004","journal-title":"Adv. Anat. Pathol."},{"key":"10.1016\/j.canlet.2006.12.029_bib32","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/pros.20490","article-title":"Quantitative multi-gene expression profiling of primary prostate cancer","volume":"66","author":"Schmidt","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2006.12.029_bib33","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1038\/sj.onc.1208518","article-title":"Frequent overexpression of ETS-related gene-1 (ERG1) in prostate cancer transcriptome","volume":"24","author":"Petrovics","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.canlet.2006.12.029_bib34","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1373\/clinchem.2005.063289","article-title":"Aptima PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer","volume":"52","author":"Groskopf","year":"2006","journal-title":"Clin. Chem."},{"key":"10.1016\/j.canlet.2006.12.029_bib35","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0302-2838(03)00201-X","article-title":"DD3(PCA3)-based molecular urine analysis for the diagnosis of prostate cancer","volume":"44","author":"Hessels","year":"2003","journal-title":"Eur. Urol."},{"issue":"Spec. No.1","key":"10.1016\/j.canlet.2006.12.029_bib36","doi-asserted-by":"crossref","first-page":"R103","DOI":"10.1093\/hmg\/ddh072","article-title":"The complex genetic epidemiology of prostate cancer","volume":"13","author":"Schaid","year":"2004","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2006.12.029_bib37","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1086\/425870","article-title":"Comparison of microsatellites versus single-nucleotide polymorphisms in a genome linkage screen for prostate cancer-susceptibility loci","volume":"75","author":"Schaid","year":"2004","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.canlet.2006.12.029_bib38","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/pros.20332","article-title":"Genome-wide linkage scan for prostate cancer aggressiveness loci using families from the university of Michigan prostate cancer genetics project","volume":"66","author":"Slager","year":"2006","journal-title":"Prostate"},{"key":"10.1016\/j.canlet.2006.12.029_bib39","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.2741\/1891","article-title":"Prostate cancer epidemiology","volume":"11","author":"Hsing","year":"2006","journal-title":"Front. Biosci."},{"key":"10.1016\/j.canlet.2006.12.029_bib40","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1093\/jnci\/djh228","article-title":"Combined genome-wide scan for prostate cancer susceptibility genes","volume":"96","author":"Gillanders","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.canlet.2006.12.029_bib41","doi-asserted-by":"crossref","first-page":"3396","DOI":"10.1158\/0008-5472.CAN-06-0168","article-title":"TMPRSS2:ETV4 gene fusions define a third molecular subtype of prostate cancer","volume":"66","author":"Tomlins","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib42","doi-asserted-by":"crossref","first-page":"8337","DOI":"10.1158\/0008-5472.CAN-06-1482","article-title":"TMPRSS2:ERG fusion-associated deletions provide insight into the heterogeneity of prostate cancer","volume":"66","author":"Perner","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1002\/gcc.20329","article-title":"Confirmation of the high frequency of the TMPRSS2\/ERG fusion gene in prostate cancer","volume":"45","author":"Soller","year":"2006","journal-title":"Genes Chromosomes Cancer"},{"key":"10.1016\/j.canlet.2006.12.029_bib44","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1593\/neo.06283","article-title":"Three-color FISH analysis of TMPRSS2\/ERG fusions in prostate cancer indicates that genomic microdeletion of chromosome 21 is associated with rearrangement","volume":"8","author":"Yoshimoto","year":"2006","journal-title":"Neoplasia"},{"key":"10.1016\/j.canlet.2006.12.029_bib45","doi-asserted-by":"crossref","first-page":"8347","DOI":"10.1158\/0008-5472.CAN-06-1966","article-title":"Expression of variant TMPRSS2\/ERG fusion messenger RNAs is associated with aggressive prostate cancer","volume":"66","author":"Wang","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib46","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1182\/blood.V98.12.3332","article-title":"Combined genomic and antisense analysis reveals that the transcription factor erg is implicated in endothelial cell differentiation","volume":"98","author":"McLaughlin","year":"2001","journal-title":"Blood"},{"issue":"Spec No 1","key":"10.1016\/j.canlet.2006.12.029_bib47","doi-asserted-by":"crossref","first-page":"R17","DOI":"10.1093\/hmg\/ddl046","article-title":"Non-coding RNA","volume":"15","author":"Mattick","year":"2006","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.canlet.2006.12.029_bib48","doi-asserted-by":"crossref","first-page":"7390","DOI":"10.1158\/0008-5472.CAN-06-0800","article-title":"MicroRNA-cancer connection: the beginning of a new tale","volume":"66","author":"Calin","year":"2006","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.gde.2006.02.012","article-title":"Gene regulation by microRNAs","volume":"16","author":"Carthew","year":"2006","journal-title":"Curr. Opin. Genet. Dev."},{"key":"10.1016\/j.canlet.2006.12.029_bib50","doi-asserted-by":"crossref","first-page":"7065","DOI":"10.1158\/0008-5472.CAN-05-1783","article-title":"MicroRNA gene expression deregulation in human breast cancer","volume":"65","author":"Iorio","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib51","first-page":"5975","article-title":"highly overexpressed in prostate cancer","volume":"59","author":"Bussemakers","year":"1999","journal-title":"Cancer Res."},{"key":"10.1016\/j.canlet.2006.12.029_bib52","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/0090-4295(94)90132-5","article-title":"Molecular staging of prostate cancer with the use of an enhanced reverse transcriptase-PCR assay","volume":"43","author":"Katz","year":"1994","journal-title":"Urology"},{"key":"10.1016\/j.canlet.2006.12.029_bib53","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0022-5347(01)64472-0","article-title":"Reverse transcriptase polymerase chain reaction for prostate specific antigen in the management of prostate cancer","volume":"158","author":"Gomella","year":"1997","journal-title":"J. Urol."},{"key":"10.1016\/j.canlet.2006.12.029_bib54","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4161\/cbt.5.3.2603","article-title":"ETS-TMPRSS2 fusion gene products in prostate cancer","volume":"5","author":"Ahlers","year":"2006","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.canlet.2006.12.029_bib55","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1186\/1471-2105-7-202","article-title":"Profiling alternatively spliced mRNA isoforms for prostate cancer classification","volume":"7","author":"Zhang","year":"2006","journal-title":"BMC Bioinformat."}],"container-title":["Cancer Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506006975?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0304383506006975?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,4,20]],"date-time":"2020-04-20T03:43:33Z","timestamp":1587354213000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0304383506006975"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,4]]},"references-count":55,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2007,4]]}},"alternative-id":["S0304383506006975"],"URL":"https:\/\/doi.org\/10.1016\/j.canlet.2006.12.029","relation":{},"ISSN":["0304-3835"],"issn-type":[{"value":"0304-3835","type":"print"}],"subject":[],"published":{"date-parts":[[2007,4]]}}}